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Plasma exosome miR-155-5p as an independent prognostic risk factor for 
Mycosis Fungoides 
Adam Cohen-Nowak, Neda Nikbakht, MD PhD* 
 
Introduction: Mycosis Fungoides (MF) is a rare non-Hodgkin Lymphoma with variable 
progression that comprises half of all cutaneous T-cell lymphomas (CTCLs). Previous 
studies have shown higher expression of the micro-RNA miR-155-5p isolated from 
biopsies of MF tumors compared to early-stage lesions and healthy skin, illustrating the 
potential for miR-155-5p to serve as a prognostic indicator. Small extracellular vesicles 
(30-150 nm) called exosomes are known to play a role in cancer signaling and 
progression by carrying micro-RNAs. However, no studies have measured circulating 
exosomal miR-155-5p in the blood of patients with MF. We hypothesize that miR-155-
5p is expressed higher in plasma exosomes of patients with MF compared to healthy 
volunteers.   
Methods: 6 patients with a diagnosis of MF and 9 healthy patients at Jefferson 
Dermatology Associates were enrolled in the study. Phlebotomy samples were obtained 
and plasma isolated by centrifugation. Exosomes were extracted by ExoQuick reagent 
and size confirmed by NanoSight software. RNA was extracted and qRT-PCR 
performed with Taqman probes for miR-155-5p and miR-103 (control). Delta-delta CT 
analysis was performed to analyze expression.   
Results: Analysis of three PCR runs determined the control (miR-103) to be expressed 
differently across samples with poor amplification. Additionally, miR-155-5p was variably 
expressed in the samples extracted from healthy volunteers. No pattern is discernible.  
Discussion: Given that sample volume is a proxy for pre-reaction cDNA in each 
sample, adaptation of the protocol and a new control is needed to more accurately 
measure miRNA expression. No conclusions can be made at this time.  
 
 
